
AI-generated illustration. Not an actual patient or treatment result.
What Is the Best Cream for Psoriasis?

Chief Medical Officer
There is no single best cream for psoriasis: for most body plaques I start with a steroid combined with calcipotriene, and I choose roflumilast or tapinarof when a steroid-free cream fits better. In its label trial, calcipotriene plus betamethasone foam left 53.3% of patients clear or almost clear after 4 weeks, compared with 4.8% on vehicle (Enstilar label). Roflumilast 0.3% cream reached 41.5% vs 5.8% at 8 weeks without any steroid (Zoryve cream label). Drugstore creams can only claim to control symptoms.
In this article
How do the prescription psoriasis creams compare?
Each number below comes from the product's own vehicle-controlled label trial. The trials used different endpoints, lengths and patients, so they cannot be compared head to head; most also required at least a 2-grade improvement.
| Product | Steroid | Result vs vehicle | Weeks | Key label limits |
|---|---|---|---|---|
| Calcipotriene plus betamethasone foam (Enstilar) | Yes | 53.3% vs 4.8% clear or almost clear | 4 | Age 12 and up; no more than 60 g every 4 days |
| Calcipotriene plus betamethasone ointment | Yes | 48.0% vs 7.6% absent or very mild | 4 | Up to 100 g a week in adults; not over 30% of the body |
| Roflumilast 0.3% cream (Zoryve) | No | 41.5% and 36.7% vs 5.8% and 7.1% | 8 | Age 2 and up, skin folds included; not with moderate or severe liver impairment |
| Calcipotriene plus betamethasone cream (Wynzora) | Yes | 37.4% vs 3.7% | 8 | Age 18 and up; up to 100 g a week |
| Halobetasol plus tazarotene lotion (Duobrii) | Yes | 36% and 45% vs 7% and 13% | 8 | About 50 g a week; not in pregnancy |
| Tapinarof 1% cream (Vtama) | No | 36% and 40% vs 6% and 6% | 12 | Adults; folliculitis in 20% vs 1% |
| Tazarotene cream (Tazorac) | No | 39% to 51% vs 24% to 26% none, minimal or mild | 12 | Not in pregnancy; itch, redness or burning in 10% to 23% |
| Calcipotriene foam (Sorilux) | No | 14% and 27% vs 7% and 16% | 8 | Age 4 and up; not on the face |
Sources for the table: Enstilar label, calcipotriene and betamethasone ointment label, Zoryve cream label, Wynzora label, Duobrii label, Vtama label, Tazorac label and Sorilux label.
What is the strongest cream for psoriasis?
Clobetasol propionate 0.05% is among the strongest: a super-potent (class 1) steroid that its label calls highly potent. It has suppressed the body's adrenal hormone axis at doses as low as 2 g a day, so its label limits treatment to 2 consecutive weeks and 50 g a week, and it is not recommended under age 12 (clobetasol ointment label). In 12 volunteers, twice-daily clobetasol for 16 days thinned normal skin by about 15% (Lubach 1995). I use the strongest cream for the shortest time that clears the plaque.
Which steroid-free creams work for psoriasis?
Roflumilast 0.3% cream and tapinarof 1% cream are the steroid-free creams I consider first. Roflumilast (Zoryve) is a phosphodiesterase-4 (PDE4) inhibitor approved from age 2, skin folds included; it reached success in 41.5% vs 5.8% and 36.7% vs 7.1% at 8 weeks (Zoryve cream label). Tapinarof (Vtama), an aryl hydrocarbon receptor agonist for adults, reached 35.4% vs 6.0% and 40.2% vs 6.3% at 12 weeks (Lebwohl 2021). Its main side effect is folliculitis, 20% vs 1%, and after clearing and stopping, the median time to first worsening was 114 days (Vtama label). Calcipotriene alone is milder: twice-daily ointment gave at least marked improvement in 70.0% at 8 weeks, but complete clearing in only 11.3% (calcipotriene ointment label).
Which cream is best for thick plaques?
For thick or chronic plaques, the American Academy of Dermatology (AAD) treatment pathway suggests a class 1 steroid for up to 4 weeks (AAD pathway). In the label trial of calcipotriene plus betamethasone ointment on trunk and limb psoriasis, the combination reached absent or very mild disease in 48.0% at 4 weeks, vs 26.3% on betamethasone alone, 16.5% on calcipotriene alone and 7.6% on vehicle (ointment label). Salicylic acid softens plaques and removes scale, says the National Psoriasis Foundation. After clearing, the AAD pathway suggests a vitamin D analog twice daily on weekdays with a high-potency steroid on weekends (AAD pathway). Twice-weekly Enstilar foam after clearing pushed the median time to first relapse to 56 days, vs 30 days on twice-weekly vehicle foam, and cut relapses from 4.8 to 3.1 a year (Lebwohl 2021, PSO-LONG). That schedule is outside the label's dosing directions, and in a 52-week label sub-study 2 of 21 adults had adrenal suppression (Enstilar label).
Does coal tar work for psoriasis, and is it safe?
Coal tar works, but slowly and messily, and a large cohort found no added cancer risk. Against calcipotriol, results are mixed: tar improved significantly only after 4 weeks in one trial (Tham 1994), while 5% coal tar ointment caught up by 12 weeks in another (69.4% vs 71.9% score reduction) (Sharma 2003). Against betamethasone valerate 0.1% cream, a cream with 10% coal tar solution (liquor carbonis detergens) did worse: 38.39% vs 69.36% mean reduction in Psoriasis Area and Severity Index score after 6 weeks (Thawornchaisit 2007). In 13,200 Dutch patients, those treated with coal tar got skin cancer and other cancers no more often than those treated with steroid creams (Roelofzen 2010). Short-term side effects are folliculitis, irritation and contact allergy (Roelofzen 2007), and 6 of 40 patients in one trial reported odor or staining (Tzaneva 2003). Tar can raise sunburn risk for up to 24 hours, and labels warn against prolonged use without consulting a doctor (21 CFR 358.750).
Do over-the-counter psoriasis creams work?
They can ease symptoms, but they are not built to clear psoriasis. Under the Food and Drug Administration (FDA) monograph, an over-the-counter (OTC) psoriasis product may contain only coal tar 0.5% to 5% or salicylic acid 1.8% to 3% (21 CFR 358.710). Its label may only claim to control or relieve itching, irritation, redness, flaking and scaling, and must tell you to consult a doctor before use if the condition covers a large area. The AAD pathway suggests salicylic acid for 8 to 16 weeks for mild psoriasis (AAD pathway). Leave-on tar products should stay off the genital area and groin unless a doctor advises it. For a few small plaques, I start here; for anything more, I start with a prescription.
When is a cream not enough?
A cream is not enough when psoriasis covers more skin than the labels or trials allow, or keeps coming back despite correct use. Calcipotriene plus betamethasone ointment is labeled for no more than 30% of the body (ointment label), and clobetasol for 50 g a week (clobetasol ointment label). The roflumilast cream trials enrolled people with 2% to 20% of their skin involved (Lebwohl 2022), and the tapinarof trials 3% to 20% (Lebwohl 2021). Past those limits, I recommend an in-person dermatology visit to discuss treatment beyond creams. If you are not sure the rash is psoriasis, see my eczema vs psoriasis guide, and if weight is part of the picture, read about GLP-1 medications and psoriasis.
How does KindleeRx treat psoriasis?
Through the KindleeRx psoriasis treatment program, licensed clinicians (physician assistants and nurse practitioners working under a board-certified dermatologist's protocols) review each case online and reply in under 5 hours on average. For mild to moderate psoriasis, when a clinician decides it is appropriate, they may prescribe the Calming Cream, a compounded cream with roflumilast 0.2% and calamine 5% used once daily. The Zoryve results above belong to branded Zoryve and do not describe it. A prescription is never guaranteed; if treatment is not prescribed, the refund is full, including the consultation fee.
Important Information
The KindleeRx Calming Cream is a compounded prescription medication containing roflumilast 0.2% and calamine 5%, prepared by a licensed US compounding pharmacy under a licensed prescriber. It is not Zoryve, it is not a generic of Zoryve, and it is not an FDA-approved drug product. Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality. KindleeRx is not affiliated with Arcutis or Zoryve. Published trial data for branded roflumilast (Zoryve) reflect the branded product and the branded concentrations studied in those trials, not this compounded formula. Eligibility is determined by a licensed clinician after reviewing your information. Not all patients qualify. This article is educational and is not medical advice.
Sources
- LEO Pharma. Enstilar (calcipotriene and betamethasone dipropionate) foam prescribing information. DailyMed 2022.
- Padagis. Calcipotriene and betamethasone dipropionate ointment prescribing information. DailyMed 2024.
- Arcutis Biotherapeutics. ZORYVE (roflumilast) cream prescribing information, revised June 2026. DailyMed.
- MC2 Therapeutics. Wynzora (calcipotriene and betamethasone dipropionate) cream prescribing information. DailyMed 2023.
- Bausch Health. Duobrii (halobetasol and tazarotene) lotion prescribing information. DailyMed 2023.
- Organon. Vtama (tapinarof) cream prescribing information. DailyMed 2025.
- Almirall. Tazorac (tazarotene) cream prescribing information. DailyMed 2025.
- Mayne Pharma. Sorilux (calcipotriene) foam prescribing information. DailyMed 2024.
- Sun Pharmaceutical. Calcipotriene ointment 0.005% prescribing information. DailyMed 2026.
- Cosette. Clobetasol propionate ointment 0.05% prescribing information. DailyMed 2023.
- Fougera. Clobetasol propionate topical solution 0.05% prescribing information. DailyMed 2026.
- Lebwohl MG, et al. Phase 3 trials of tapinarof for the treatment of psoriasis. New England Journal of Medicine 2021.
- Lebwohl MG, et al. DERMIS-1 and DERMIS-2 trials of roflumilast cream 0.3% in plaque psoriasis. JAMA 2022.
- Lebwohl M, et al. PSO-LONG: long-term twice-weekly calcipotriene and betamethasone foam. Journal of the American Academy of Dermatology 2021.
- Lubach D, et al. Skin thinning with clobetasol propionate in volunteers. Dermatology 1995.
- Tham SN, et al. Calcipotriol ointment vs coal tar solution in psoriasis. British Journal of Dermatology 1994.
- Sharma V, et al. 5% coal tar ointment vs calcipotriol in psoriasis. International Journal of Dermatology 2003.
- Thawornchaisit P, Harncharoen K. Coal tar cream vs betamethasone valerate cream in psoriasis. Journal of the Medical Association of Thailand 2007.
- Roelofzen JH, et al. No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema. Journal of Investigative Dermatology 2010.
- Tzaneva S, et al. 1% coal tar preparation vs calcipotriol cream in psoriasis. British Journal of Dermatology 2003.
- Roelofzen JH, et al. Coal tar in dermatology. Journal of Dermatological Treatment 2007.
- US Code of Federal Regulations. 21 CFR Part 358, Subpart H: drug products for the control of dandruff, seborrheic dermatitis, and psoriasis. eCFR.
- American Academy of Dermatology. Management of adult psoriasis with topicals: clinical pathway, May 2023 update.
- National Psoriasis Foundation. Scalp psoriasis.
Related Articles

Psoriasis
GLP-1 for Psoriasis: How Weight Loss Can Improve Skin Clearance
May 17, 2026 · 13 min read

Psoriasis
When Weight Is Part of the Psoriasis Story: The Conversation That Often Gets Missed
May 18, 2026 · 10 min read

Eczema
Eczema vs. Psoriasis: The 5-Minute Guide to Getting the Right Diagnosis
Feb 15, 2026 · 13 min read
